Results 311 to 320 of about 1,472,301 (348)
Some of the next articles are maybe not open access.
The Lancet Oncology, 2020
BACKGROUND The first interim analysis of the KEYNOTE-426 study showed superior efficacy of pembrolizumab plus axitinib over sunitinib monotherapy in treatment-naive, advanced renal cell carcinoma. The exploratory analysis with extended follow-up reported
T. Powles +19 more
semanticscholar +1 more source
BACKGROUND The first interim analysis of the KEYNOTE-426 study showed superior efficacy of pembrolizumab plus axitinib over sunitinib monotherapy in treatment-naive, advanced renal cell carcinoma. The exploratory analysis with extended follow-up reported
T. Powles +19 more
semanticscholar +1 more source
Current Opinion in Oncology, 2003
Renal cell carcinoma (RCC) continues to present a diagnostic and therapeutic challenge. The increased use of abdominal imaging studies does not appear to completely account for the rising incidence of RCC. Alcohol consumption has been found to be a possible protective factor among women in a recent study, but among women with children, RCC risk may ...
Young E, Whang, Paul A, Godley
openaire +2 more sources
Renal cell carcinoma (RCC) continues to present a diagnostic and therapeutic challenge. The increased use of abdominal imaging studies does not appear to completely account for the rising incidence of RCC. Alcohol consumption has been found to be a possible protective factor among women in a recent study, but among women with children, RCC risk may ...
Young E, Whang, Paul A, Godley
openaire +2 more sources
RENAL BOTRYOMYCOSIS MIMICKING RENAL CELL CARCINOMA
Journal of Urology, 1998Botxyomycosis is characterized by a chronic suppurative lesion with distinctive fungus-like grains similar to sulfur granules in actinomycosis.1 The integumentary and visceral forms are recognized.’ Only 2 of the previously reported 6 renal botryomycosis cases were isolated, which simulated renal cell carcinoma radiologically and clinically, and ...
Sade, M +4 more
openaire +3 more sources
Pediatric renal cell carcinoma
Journal of Pediatric Urology, 2009Renal cell carcinoma (RCC) comprises about 5% of pediatric renal neoplasms. It has been recognized as a second malignancy in multiple reports. It is generally symptomatic at diagnosis, and most children with RCC present with more locally advanced disease than do adults.
Justin E, Sausville +3 more
openaire +2 more sources
Multiloculated renal cell carcinoma
International Urology and Nephrology, 1991Multiloculated renal cell carcinoma and multilocular renal cyst with renal cell carcinoma are uncommon diseases. We report on 2 cases of multiloculated renal cell carcinoma. To our knowledge 16 cases of multiloculated renal cell carcinoma and multilocular renal cyst with renal cell carcinoma have been previously described in detail.
S, Koga +7 more
openaire +2 more sources
Journal of Urology, 1988
There are 12 000–17 000 new cases of renal cell carcinoma in the United States per year. Renal cell carcinoma is responsible for 7000 to 9000 deaths annually. Approximately 56% of the cases are localized, 14% are locally advanced, and 30% of patients present with metastatic disease.
openaire +2 more sources
There are 12 000–17 000 new cases of renal cell carcinoma in the United States per year. Renal cell carcinoma is responsible for 7000 to 9000 deaths annually. Approximately 56% of the cases are localized, 14% are locally advanced, and 30% of patients present with metastatic disease.
openaire +2 more sources
Current Treatment Options in Oncology, 2000
For most patients with advanced renal cell carcinoma, treatment remains palliative. Standard chemotherapy used in the treatment of other types of cancers has proven ineffective in the treatment of this disease. High-dose interleukin-2 (IL-2) is the only regimen that has consistently shown benefit in advanced renal cell carcinoma.
B G, Redman, A E, Chang
openaire +2 more sources
For most patients with advanced renal cell carcinoma, treatment remains palliative. Standard chemotherapy used in the treatment of other types of cancers has proven ineffective in the treatment of this disease. High-dose interleukin-2 (IL-2) is the only regimen that has consistently shown benefit in advanced renal cell carcinoma.
B G, Redman, A E, Chang
openaire +2 more sources
Targeting Renal Cell Carcinoma
Journal of Clinical Oncology, 2009Recent discovery and clinical development of targeted agents have expanded treatment options in renal cell carcinoma (RCC) and have improved prognosis for patients with RCC metastases. Because RCC displays nearly universal resistance to chemotherapy, it has long been considered a model tumor for studying drug resistance.
Robert J, Motzer, Ana M, Molina
openaire +2 more sources
Current Opinion in Oncology, 1991
The behavior of renal cell carcinoma remains one of the most unpredictable of the genitourinary neoplasms. Once this disease has spread beyond the confines of the kidney, it is extremely difficult to control. This year, emphasis has focused on the characteristic cytogenetic and chromosomal changes that are seen in this tumor that help to explain ...
openaire +3 more sources
The behavior of renal cell carcinoma remains one of the most unpredictable of the genitourinary neoplasms. Once this disease has spread beyond the confines of the kidney, it is extremely difficult to control. This year, emphasis has focused on the characteristic cytogenetic and chromosomal changes that are seen in this tumor that help to explain ...
openaire +3 more sources